Korro Bio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KRRO research report →
About the company
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
- CEO
- Ram Aiyar
- IPO
- 2019
- Employees
- 112
- HQ
- Cambridge, MA, US
Price Chart
- Market Cap
- $139.35M
- P/E
- -1.20
- P/S
- 36.27
- P/B
- 1.36
- EV/EBITDA
- -1.54
- Div Yield
- 0.00%
- Gross Margin
- 73.22%
- Op Margin
- -2154.03%
- Net Margin
- -2954.14%
- ROE
- -117.86%
- ROIC
- -48.22%
- Revenue
- $6.39M · 181.46%
- Net Income
- $-117,260,000 · -40.30%
- EPS
- $-12.48 · -33.19%
- Op Income
- $-87,342,000
- FCF YoY
- -1.41%
- 52W High
- $55.89
- 52W Low
- $5.20
- 50D MA
- $12.15
- 200D MA
- $16.87
- Beta
- 2.10
- Avg Volume
- 175.57K
Get TickerSpark's AI analysis on KRRO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 22, 26 | FORMELA JEAN FRANCOIS | sell | 3,382 |
| Jun 23, 26 | FORMELA JEAN FRANCOIS | sell | 101,579 |
| Jun 24, 26 | FORMELA JEAN FRANCOIS | sell | 40,679 |
| Jun 24, 26 | FORMELA JEAN FRANCOIS | sell | 666 |
| Jun 22, 26 | FORMELA JEAN FRANCOIS | sell | 580 |
| Jun 23, 26 | FORMELA JEAN FRANCOIS | sell | 17,426 |
| Jun 24, 26 | FORMELA JEAN FRANCOIS | sell | 6,979 |
| Jun 24, 26 | FORMELA JEAN FRANCOIS | sell | 114 |
| Jun 16, 26 | Chappell Todd | sell | 3,168 |
| Jun 16, 26 | Vincent Loic A | sell | 3,418 |
Our KRRO coverage
Recent articles, reports, and earnings notes.
No research on KRRO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KRRO report →Similar companies
Peers in the same neighborhood.